EPHB4 and breast cancer: EphB4, in breast cancer cells, activates an anti-oncogenic Abl-Crk pathway, inhibiting cell viability, proliferation, motility, and invasion, and downregulates the pro-invasive matrix metalloprotease, MMP-2 [13].